0000950170-23-043479.txt : 20230818 0000950170-23-043479.hdr.sgml : 20230818 20230818163021 ACCESSION NUMBER: 0000950170-23-043479 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230801 FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cullen Kevin Joseph CENTRAL INDEX KEY: 0001858836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39242 FILM NUMBER: 231186215 MAIL ADDRESS: STREET 1: AVEO PHARMACEUTICALS, INC. STREET 2: 30 WINTER STREET CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: California BanCorp CENTRAL INDEX KEY: 0001752036 STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022] IRS NUMBER: 821751097 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1300 CLAY STREET STREET 2: SUITE 500 CITY: OAKLAND STATE: CA ZIP: 94612 BUSINESS PHONE: 510-457-3769 MAIL ADDRESS: STREET 1: 1300 CLAY STREET STREET 2: SUITE 500 CITY: OAKLAND STATE: CA ZIP: 94612 4 1 ownership.xml 4 X0508 4 2023-08-01 0001752036 California BanCorp CALB 0001858836 Cullen Kevin Joseph 1300 CLAY STREET, SUITE 500 OAKLAND CA 94612 true false false false false Common Stock 2023-08-01 4 A false 645 18.60 A 45894 D These shares were issued to the reporting person under the issuer's Amended and Restated 2017 Equty Incentive Plan in lieu of director retainer and meeting fees of $12,000. /s/ Kevin J. Cullen, by Debra Bradford, attorney-in-fact 2023-08-18